Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02638597 · ClinicalTrials.gov registry record · Phase 2
Gemfibrozil for Nicotine Smoking Cessation
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT02638597 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 16 participants.
The verdict
NCT02638597, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
This project will test whether gemfibrozil, a well-studied medication for high cholesterol, will help people stop smoking nicotine cigarette smoking. The study will also test whether gemfibrozil decrease cravings for cigarette and the desire to smoke.
Interventions
- BEHAVIORAL smoking cessation counseling
- DRUG Gemfibrozil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-12-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02638597
The ClinicalTrials.gov registry entry for NCT02638597 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which smoking cessation counseling is the first listed.
NCT02638597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02638597 about?
NCT02638597 is a clinical study titled "Gemfibrozil for Nicotine Smoking Cessation". This project will test whether gemfibrozil, a well-studied medication for high cholesterol, will help people stop smoking nicotine cigarette smoking. The study will also test whether gemfibrozil decrease cravings for cigarette and the desire to smoke.
What is the current status of trial NCT02638597?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2015-02. Estimated completion is 2016-12-23.
What interventions are being tested in trial NCT02638597?
The interventions under investigation include: smoking cessation counseling (BEHAVIORAL), Gemfibrozil (DRUG).
Who is sponsoring clinical trial NCT02638597?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.